Moolec Science SA Ordinary Shares (MLEC)vsRevolution Medicines Inc (RVMD)
MLEC
Moolec Science SA Ordinary Shares
$1.51
+2.72%
HEALTHCARE · Cap: $1.25M
RVMD
Revolution Medicines Inc
$188.72
+1.34%
HEALTHCARE · Cap: $38.14B
Smart Verdict
WallStSmart Research — data-driven comparison
Moolec Science SA Ordinary Shares generates 956% more annual revenue ($7.83M vs $742,000). RVMD leads profitability with a 0.0% profit margin vs 0.0%. MLEC earns a higher WallStSmart Score of 36/100 (F).
MLEC
Hold36
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 948.0% year-over-year
Reasonable price relative to book value
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Operating margin of 0.0%
Trading at 15.5x book value
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : MLEC
The strongest argument for MLEC centers on Revenue Growth, Price/Book. Revenue growth of 948.0% demonstrates continued momentum.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : MLEC
The primary concerns for MLEC are EPS Growth, Market Cap, Profit Margin. Debt-to-equity of 7.21 is elevated, increasing financial risk.
Bear Case : RVMD
The primary concerns for RVMD are Price/Book, EPS Growth, Profit Margin.
Key Dynamics to Monitor
MLEC profiles as a hypergrowth stock while RVMD is a value play — different risk/reward profiles.
RVMD carries more volatility with a beta of 1.40 — expect wider price swings.
MLEC is growing revenue faster at 948.0% — sustainability is the question.
MLEC generates stronger free cash flow (-30M), providing more financial flexibility.
Bottom Line
MLEC scores higher overall (36/100 vs 24/100) and 948.0% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Moolec Science SA Ordinary Shares
HEALTHCARE · BIOTECHNOLOGY · USA
Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company is headquartered in Luxembourg.
Visit Website →Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?